Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Tolerogenic signaling of alveolar macrophages induces lung adaptation to oxidative injury.

Allard B, Panariti A, Pernet E, Downey J, Ano S, Dembele M, Nakada E, Fujii U, McGovern TK, Powell WS, Divangahi M, Martin JG.

J Allergy Clin Immunol. 2019 Oct;144(4):945-961.e9. doi: 10.1016/j.jaci.2019.07.015. Epub 2019 Jul 26.

PMID:
31356919
2.

A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation.

Morichika D, Miyahara N, Fujii U, Taniguchi A, Oda N, Senoo S, Kataoka M, Tanimoto M, Kakuta H, Kiura K, Maeda Y, Kanehiro A.

Respir Res. 2019 Jan 3;20(1):2. doi: 10.1186/s12931-018-0963-0.

3.

Requirement for neuropeptide Y in the development of type 2 responses and allergen-induced airway hyperresponsiveness and inflammation.

Oda N, Miyahara N, Taniguchi A, Morichika D, Senoo S, Fujii U, Itano J, Gion Y, Kiura K, Kanehiro A, Maeda Y.

Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L407-L417. doi: 10.1152/ajplung.00386.2018. Epub 2019 Jan 3.

PMID:
30604629
4.

Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.

Oda N, Miyahara N, Senoo S, Itano J, Taniguchi A, Morichika D, Fujii U, Maeda Y, Kiura K, Kanehiro A.

Allergol Int. 2018 Oct;67(4):521-523. doi: 10.1016/j.alit.2018.03.004. Epub 2018 Apr 14. No abstract available.

5.

Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary Disease.

Taniguchi A, Miyahara N, Oda N, Morichika D, Ichihara E, Oze I, Tanimoto Y, Ichikawa H, Fujii U, Tanimoto M, Kanehiro A, Kiura K.

Acta Med Okayama. 2017 Oct;71(5):453-457. doi: 10.18926/AMO/55446.

6.

Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma.

Fujii U, Miyahara N, Taniguchi A, Oda N, Morichika D, Murakami E, Nakayama H, Waseda K, Kataoka M, Kakuta H, Tanimoto M, Kanehiro A.

Respir Res. 2017 Jan 23;18(1):23. doi: 10.1186/s12931-017-0507-z.

7.

IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema.

Fujii U, Miyahara N, Taniguchi A, Waseda K, Morichika D, Kurimoto E, Koga H, Kataoka M, Gelfand EW, Cua DJ, Yoshimura A, Tanimoto M, Kanehiro A.

Am J Respir Cell Mol Biol. 2016 Nov;55(5):697-707.

PMID:
27351934
8.

Contrasting roles for the receptor for advanced glycation end-products on structural cells in allergic airway inflammation vs. airway hyperresponsiveness.

Taniguchi A, Miyahara N, Waseda K, Kurimoto E, Fujii U, Tanimoto Y, Kataoka M, Yamamoto Y, Gelfand EW, Yamamoto H, Tanimoto M, Kanehiro A.

Am J Physiol Lung Cell Mol Physiol. 2015 Oct 15;309(8):L789-800. doi: 10.1152/ajplung.00087.2015. Epub 2015 Aug 21.

9.

Emphysema requires the receptor for advanced glycation end-products triggering on structural cells.

Waseda K, Miyahara N, Taniguchi A, Kurimoto E, Ikeda G, Koga H, Fujii U, Yamamoto Y, Gelfand EW, Yamamoto H, Tanimoto M, Kanehiro A.

Am J Respir Cell Mol Biol. 2015 Apr;52(4):482-91. doi: 10.1165/rcmb.2014-0027OC.

PMID:
25188021

Supplemental Content

Support Center